Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic applications of CpG-containing oligodeoxynucleotides.

× No keyword cloud information.

10 in total

1. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

Authors: D M Klinman; J Conover; C Coban
Journal: Infect Immun Date: 1999-11 Impact factor: 3.441

Review 2. Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety.

Authors: D M Klinman; S Kamstrup; D Verthelyi; I Gursel; K J Ishii; F Takeshita; M Gursel
Journal: Springer Semin Immunopathol Date: 2000

3. Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.

Authors: Anne-Sophie Beignon; Jean-Paul Briand; Sylviane Muller; Charalambos D Partidos
Journal: Immunology Date: 2002-02 Impact factor: 7.397

Review 4. Novel vaccine development strategies for inducing mucosal immunity.

Authors: Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal: Expert Rev Vaccines Date: 2012-03 Impact factor: 5.217

Review 5. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.

Authors: Kosuke Kataoka; Yoshiko Fukuyama; David E Briles; Tatsuro Miyake; Kohtaro Fujihashi
Journal: Microbiol Immunol Date: 2017-06 Impact factor: 1.955

Review 6. Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.

Authors: Kosuke Kataoka; Kohtaro Fujihashi
Journal: Expert Rev Vaccines Date: 2009-09 Impact factor: 5.217

7. DNA containing CpG motifs induces angiogenesis.

Authors: Mei Zheng; Dennis M Klinman; Malgorzata Gierynska; Barry T Rouse
Journal: Proc Natl Acad Sci U S A Date: 2002-06-11 Impact factor: 11.205

8. Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families.

Authors: Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Peter F Moore; Monika Engels; Marco Franchini; Regina Hofmann-Lehmann; Hans Lutz
Journal: Vet Res Date: 2012-08-20 Impact factor: 3.683

9. CpG Immunotherapy in Chenopodium album sensitized mice: The comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations.

Authors: Tahereh Mousavi; Nader Tajik; Maziar Moradi; Masoomeh Fallah Radjabzadeh
Journal: Clin Mol Allergy Date: 2008-09-17

10. Broad-spectrum drugs against viral agents.

Authors: Mary E Christopher; Jonathan P Wong
Journal: Int J Mol Sci Date: 2008-09-01 Impact factor: 6.208

10 in total